<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Laboratory Corp. of America Holdings - Google Finance</title>
<description>News for Laboratory Corp. of America Holdings - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:LH&amp;amp;client=news-rss&amp;amp;ei=B0DBUeCvOa7q0QHNTw</link>
<image>
<title>News for Laboratory Corp. of America Holdings - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:LH&amp;amp;client=news-rss&amp;amp;ei=B0DBUeCvOa7q0QHNTw</link>
</image>
<item>
<title>LABORATORY CORP. OF AMERICA HOLDINGS : LabCorp Announces ...</title>
<link>http://www.4-traders.com/LABORATORY-CORP-OF-AMERI-13392/news/Laboratory-Corp-of-America-Holdings-LabCorp-Announces-Availability-of-Newly-Approved-Viral-Load-A-17027781/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778183643383</guid>
<pubDate>Mon, 17 Jun 2013 21:17:33 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/LABORATORY-CORP-OF-AMERI-13392/news/Laboratory-Corp-of-America-Holdings-LabCorp-Announces-Availability-of-Newly-Approved-Viral-Load-A-17027781/&quot; style=&quot;font-size:1.2em&quot;&gt;LABORATORY CORP. OF AMERICA HOLDINGS : LabCorp Announces ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Laboratory Corp. of America Holdings : LabCorp Announces Availability of Newly Approved Viral Load Assay for Hepatitis C Virus.&lt;/div&gt;
&lt;a href=&quot;http://laboratoryinstrumentation.pharmaceutical-business-review.com/news/labcorp-offers-roches-viral-load-assay-for-hepatitis-c-virus-180613&quot;&gt;LabCorp offers Roche&amp;#39;s viral load assay for hepatitis C virus&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Pharmaceutical Business Review&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Laboratory Corp. of America Holdings (LH): Insiders Aren&amp;#39;t Crazy About It</title>
<link>http://www.insidermonkey.com/blog/laboratory-corp-of-america-holdings-lh-insiders-arent-crazy-about-it-157212/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778173221433</guid>
<pubDate>Sun, 02 Jun 2013 02:01:05 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/laboratory-corp-of-america-holdings-lh-insiders-arent-crazy-about-it-157212/&quot; style=&quot;font-size:1.2em&quot;&gt;Laboratory Corp. of America Holdings (LH): Insiders Aren&amp;#39;t Crazy About It&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 2, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Laboratory Corp. of America Holdings (NYSE:LH) has experienced an increase in support from the world&amp;#39;s most elite money managers in recent months.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Realty Income Larger Than S&amp;amp;P 500 Component Laboratory Corporation of ...</title>
<link>http://www.forbes.com/sites/dividendchannel/2013/05/29/realty-income-larger-than-sp-500-component-laboratory-corporation-of-america-holdings/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778170910351</guid>
<pubDate>Wed, 29 May 2013 20:42:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.forbes.com/sites/dividendchannel/2013/05/29/realty-income-larger-than-sp-500-component-laboratory-corporation-of-america-holdings/&quot; style=&quot;font-size:1.2em&quot;&gt;Realty Income Larger Than S&amp;amp;P 500 Component Laboratory Corporation of ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Forbes&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... (factoring in those share counts) creates a true “apples-to-apples” comparison of the value of two stocks. In the case of Realty Income Corp.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Laboratory Corp. of America Receives Neutral Rating from Zacks (LH)</title>
<link>http://www.watchlistnews.com/2013/06/13/laboratory-corp-of-america-receives-neutral-rating-from-zacks-lh/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.watchlistnews.com/2013/06/13/laboratory-corp-of-america-receives-neutral-rating-from-zacks-lh/</guid>
<pubDate>Thu, 13 Jun 2013 12:26:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.watchlistnews.com/2013/06/13/laboratory-corp-of-america-receives-neutral-rating-from-zacks-lh/&quot; style=&quot;font-size:1.2em&quot;&gt;Laboratory Corp. of America Receives Neutral Rating from Zacks (LH)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Watch List News (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Laboratory Corporation of America Holdings is a clinical laboratory company. As of December 31, 2011, it had a national network of 54 primary laboratories and over 1,700 patient service centers (NYSE: LH) along with a network of branches and STAT&amp;nbsp;...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Laboratory Corp. of America Given Neutral Rating at JPMorgan Chase (LH)</title>
<link>http://www.watchlistnews.com/2013/06/13/laboratory-corp-of-america-given-neutral-rating-at-jpmorgan-chase-lh/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778180476804</guid>
<pubDate>Thu, 13 Jun 2013 15:44:52 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.watchlistnews.com/2013/06/13/laboratory-corp-of-america-given-neutral-rating-at-jpmorgan-chase-lh/&quot; style=&quot;font-size:1.2em&quot;&gt;Laboratory Corp. of America Given Neutral Rating at JPMorgan Chase (LH)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Watch List News (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Laboratory Corporation of America Holdings is a clinical laboratory company. As of December 31, 2011, it had a national network of 54 primary laboratories and over 1,700 patient service centers (NYSE: LH) along with a network of branches and STAT&amp;nbsp;...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>SunTrust Reiterates “Buy” Rating for Laboratory Corp. of America (LH)</title>
<link>http://www.watchlistnews.com/2013/05/30/suntrust-reiterates-buy-rating-for-laboratory-corp-of-america-lh/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778172576312</guid>
<pubDate>Thu, 30 May 2013 13:24:39 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.watchlistnews.com/2013/05/30/suntrust-reiterates-buy-rating-for-laboratory-corp-of-america-lh/&quot; style=&quot;font-size:1.2em&quot;&gt;SunTrust Reiterates “Buy” Rating for Laboratory Corp. of America (LH)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Watch List News (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 30, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Laboratory Corp. of America has set its FY13 guidance at $6.85-7.15 EPS. Analysts expect that Laboratory Corp. of America will post $7.11 EPS for the current fiscal year. Laboratory Corporation of America Holdings is a clinical laboratory company.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>LabCorp Announces Availability of Newly Approved Viral Load Assay for ...</title>
<link>http://www.dailyfinance.com/2013/06/17/labcorp-announces-availability-of-newly-approved-v/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.dailyfinance.com/2013/06/17/labcorp-announces-availability-of-newly-approved-v/</guid>
<pubDate>Tue, 18 Jun 2013 10:55:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.dailyfinance.com/2013/06/17/labcorp-announces-availability-of-newly-approved-v/&quot; style=&quot;font-size:1.2em&quot;&gt;LabCorp Announces Availability of Newly Approved Viral Load Assay for ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;DailyFinance&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;18 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;BURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America® Holdings (LabCorp®) (NYS: LH) today announced that it is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Medicare spends $900 million too much on Quest Diagnostics, other labs: audit</title>
<link>http://www.nj.com/business/index.ssf/2013/06/medicare_spends_900_million_to.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778178320254</guid>
<pubDate>Wed, 12 Jun 2013 14:17:19 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nj.com/business/index.ssf/2013/06/medicare_spends_900_million_to.html&quot; style=&quot;font-size:1.2em&quot;&gt;Medicare spends $900 million too much on Quest Diagnostics, other labs: audit&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;The Star-Ledger - NJ.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 12, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Quest Diagnostics Inc. and Laboratory Corporation of America Holdings, the two largest lab services companies in the U.S., each receive at least 15 percent of their annual revenue from Medicare, according to data compiled by Bloomberg. Spokesmen for ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Verastem Investigational Mesothelioma Treatment Gets Orphan Status in EU</title>
<link>http://online.wsj.com/article/BT-CO-20130613-704545.html?mod=googlenews_wsj</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778180809533</guid>
<pubDate>Thu, 13 Jun 2013 11:50:34 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://online.wsj.com/article/BT-CO-20130613-704545.html?mod=googlenews_wsj&quot; style=&quot;font-size:1.2em&quot;&gt;Verastem Investigational Mesothelioma Treatment Gets Orphan Status in EU&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Wall Street Journal&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Verastem, which went public last year, is developing a biomarker test with Laboratory Corp. of America Holdings (LH) to identify a subgroup of mesothelioma patients low in a marker called Merlin.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Qiagen Attempts to Expand NGS Platform - Analyst Blog</title>
<link>http://www.nasdaq.com/article/qiagen-attempts-to-expand-ngs-platform-analyst-blog-cm252424</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778179623426</guid>
<pubDate>Tue, 11 Jun 2013 21:30:49 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/qiagen-attempts-to-expand-ngs-platform-analyst-blog-cm252424&quot; style=&quot;font-size:1.2em&quot;&gt;Qiagen Attempts to Expand NGS Platform - Analyst Blog&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;NASDAQ&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 11, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Qiagen is facing intense competition in the molecular diagnostic space, especially from Laboratory Corp of America Holdings ( LH ). Currently, Qiagen retains a Zacks Rank #3 (Hold). However, other stocks in the medical device sector like Haemonetics Inc.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
